Facebook Pixel Infective Endocarditis | PRIME Magazine - Health - Magzter.comでこの記事を読む
Magzter GOLDで無制限に

Magzter GOLDで無制限に

10,000以上の雑誌、新聞、プレミアム記事に無制限にアクセスできます。

$149.99
 
$74.99/年

試す - 無料

Infective Endocarditis

PRIME Magazine

|

December 2017 - January 2018

A damage in the inner lining of the heart chambers and heart valves usually caused by a bacteria, fungi or other germs from another part of the body that spread through the bloodstream and attach to damaged areas in your heart. It is uncommon to people with healthy hearts, while those with damaged heart valves, artificial heart valves or other heart defects are of greater risks.

Infective Endocarditis

Symptoms of endocarditis are not always severe, and they may develop slowly over time. In the early stages of endocarditis, the symptoms are similar to many other illnesses. This is why many cases go undiagnosed. Many of the symptoms are similar to cases of the flu or general infections, such as pneumonia. However, some people experience severe symptoms that appear suddenly, such as: swollen feet, shortness of breath, blood in the urine or an enlarged spleen, which may be tender to touch. These symptoms may be due to inflammation or the damage it causes.

PRIME Magazine からのその他のストーリー

PRIME Singapore

PRIME Singapore

Living Large

The Illusion of Space in Small Homes

time to read

9 mins

February - March 2026

PRIME Singapore

PRIME Singapore

Fend Off the Flames

Fire Safety Knowledge That Can Save Lives

time to read

7 mins

February - March 2026

PRIME Singapore

PRIME Singapore

The World in Numbers

How Data Analytics Shapes Modern Decision-Making

time to read

14 mins

February - March 2026

PRIME Singapore

PRIME Singapore

Thunder Struck

Chris Hemsworth: From God of Thunder to Hollywood Deity

time to read

29 mins

February - March 2026

PRIME Singapore

PRIME Singapore

Ingesting Inflammation

Why Everyone is Talking About Anti-Inflammatory Diets

time to read

12 mins

February - March 2026

PRIME Singapore

Inked Later

Why More People Are Getting Tattoos After 40

time to read

7 mins

February - March 2026

PRIME Singapore

PRIME Singapore

STUDY CONFIRMS ONE MONTH OF NO ALCOHOL MAKES REAL DIFFERENCE TO HEALTH

In 2013, Alcohol Change UK started the “Dry January” campaign, where people could commit to abstaining from drinking alcohol for the entire month.

time to read

2 mins

February - March 2026

PRIME Singapore

CERTAIN CHANGES IN DRIVING PATTERNS MAY POINT TO COGNITIVE DECLINE, DEMENTIA

Individuals with cognitive impairment are at a two-to five-fold increased risk of being involved in motor accidents, highlighting the deterioration of driving skills with a decline in cognitive function. A recent study published in Neurology suggests that changes in daily driving patterns recorded using a vehicle datalogger could reliably distinguish individuals with mild cognitive impairment (MCI) from those with normal cognition. The study’s findings suggest that data collected by vehicle data loggers could potentially be used in the early identification of individuals at risk of a motor crash or those with cognitive impairment, prior to in-person cognitive assessments or brain imaging scans. Driving data patterns could also serve as a tool to assess the effectiveness of interventions for treating cognitive impairment.

time to read

2 mins

February - March 2026

PRIME Singapore

PRIME Singapore

LIFT ME UP

Volformer: The Rejuvenation Protocol Combining Precision Ultrasound and Volumetric RF

time to read

4 mins

February - March 2026

PRIME Singapore

PRIME Singapore

TARGETING IDO1 FOR CANCER: NOVEL DEGRADERS SHOW PROMISE IN PRECLINICAL STUDIES

Cancer cells employ a variety of strategies to evade the immune system, and modern immunotherapies aim precisely at these escape mechanisms. However, such therapies are not always successful. A research team from the Max Planck Institute for Molecular Physiology in Dortmund and the AITHYRA Institute in Vienna has now developed a new class of compounds that specifically target and destroy the enzyme IDO1 – a key molecular switch that tumours use to suppress immune responses. They were also able to show that iDegs (IDO1 degraders) inhibit tumour growth in mice with SKOV-3 tumours, thereby prolonging survival time. This approach could markedly enhance the efficacy of existing immunotherapies and open new avenues in the fight against cancer. The new research was published in the journal Nature.

time to read

3 mins

February - March 2026

Translate

Share

-
+

Change font size